Literature DB >> 3197418

Post-tubal sterilization problems correlated with ovarian steroidogenesis.

J F Cattanach1, B J Milne.   

Abstract

Mid-luteal phase total urinary oestrogen excretion was found to be significantly reduced in women who had previously undergone tubal sterilization at least two years before assay; pregnanediol levels at or below 2.0 mg/24 hrs were significantly more frequent for the study group. These findings indicate that reduced ovarian function is associated with that procedure. The major problems declared as having been experienced subsequent to tubal sterilization were classified into three categories; some women declared problems in more than one category: (1) Abnormal uterine bleeding and/or menorrhagia, (2) Physical problems, (3) Psychological and/or psychiatric problems. Category 1 was associated with a significant fall in total oestrogen excretion, and category 2 with a significant fall in both total oestrogen and pregnanediol excretion. Analysis of category 3 will be published elsewhere. A negative correlation between total oestrogens and cholesterol was observed.

Entities:  

Keywords:  Australia; Biology; Clinical Research; Corpus Luteum Hormones; Developed Countries; Developing Countries; Diseases; Economic Factors; Endocrine Effects; Endocrine System; Estradiol; Estrogens; Family Planning; Female Sterilization--complications; Fibroadenosis; Gastrointestinal Effects; Genitalia; Genitalia, Female; Hormones; Human Volunteers; Hypertension; Lipid Metabolic Effects; Lipids; Mammary Gland Effects; Menstrual Cycle; Menstruation; Mental Disorders; Metabolic Effects; Morbidity; Oceania; Ovary; Physiology; Progestational Hormones; Progesterone; Reproduction; Research And Development; Research Methodology; Sterilization, Sexual; Technology; Urogenital System; Vascular Diseases; Venous Engorgement

Mesh:

Substances:

Year:  1988        PMID: 3197418     DOI: 10.1016/0010-7824(88)90157-6

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.

Authors:  Tsogzolmaa Dorjgochoo; Xiao-Ou Shu; Hong-Lan Li; Han-Zhu Qian; Gong Yang; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

2.  Tubal ligation and the risk of vertebral fractures.

Authors:  Grace Wyshak
Journal:  Osteoporos Int       Date:  2004-09-29       Impact factor: 4.507

3.  Prooxidant-antioxidant balance and malondialdehyde over time in adult rats after tubal sterilization and vasectomy.

Authors:  Azita Faramarzi; Behjat Seifi; Hamid Reza Sadeghipour; Alireza Shabanzadeh; Mitra Ebrahimpoor
Journal:  Clin Exp Reprod Med       Date:  2012-06-30

4.  The risk of menstrual abnormalities after tubal sterilization: a case control study.

Authors:  Mehri Jafari Shobeiri; Simin Atashkhoii
Journal:  BMC Womens Health       Date:  2005-05-02       Impact factor: 2.809

5.  Tubal ligation and risk of breast cancer.

Authors:  L A Brinton; M D Gammon; R J Coates; R N Hoover
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

6.  The comparison of the degree of apoptosis in ovaries and fallopian tubes between two different surgical interventions for tubal ligation: A rat model.

Authors:  Sezcan Mümüşoğlu; Servet Hacıvelioğlu; Lale Karakoç Sökmensüer; Rengin Karataylı; Ayşegül Süzer; Figen Kaymaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-01-30

7.  High Prevalence of Asymptomatic Intracranial Atherosclerosis in Elder Women With Tubal Ligation: Result From a Community-Based Study in Shandong, China.

Authors:  Xiaotong Ma; Shaowei Sang; Yuanyuan Zhao; Xiang Wang; Xiaokang Ji; Sai Shao; Guangbin Wang; Fuzhong Xue; Yifeng Du; Ming Lv; Qinjian Sun
Journal:  Front Cardiovasc Med       Date:  2022-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.